✅ Yes, the content about Hims & Hers stock surging amid excitement over their Super Bowl ad and upcoming financial results appears to be true and authentic, as reported by several credible sources.

These include:

1. Stocktwits reported a nearly 4% jump in Hims & Hers Health Inc. shares in early premarket trading after airing a provocative Super Bowl ad targeting Big Pharma and the weight-loss industry, fueling bullish retail sentiment and ambitious price targets for the stock.

https://stocktwits.com/news-articles/markets/equity/hims-stock-jumps-after-super-bowl-ad-controversy/ch5E4nYRtl (Trust Score 7/10)

2. Fierce Healthcare noted a 650% spike in traffic and record-breaking new customer registrations on Hims & Hers platforms following their Super Bowl ad. The ad generated significant engagement, pushing their app to #2 in the Apple Store Health & Wellness category. Share prices rose about 10% that week, up 83% for the year so far.

https://www.fiercehealthcare.com/health-tech/hims-hers-sees-650-spike-traffic-following-super-bowl-ad-clash-over-compounded-glp-1s (Trust Score 7.5/10)

3. Good Morning America covered the ad controversy, highlighting the ad’s message on expensive weight-loss drugs and Hims & Hers’ more affordable compounded alternatives. The piece confirms the ad's airing during the 2025 Super Bowl and its impact on public discourse and stock activity.

https://www.goodmorningamerica.com/wellness/story/super-bowl-ad-hims-weight-loss-drug-sparks-118695064 (Trust Score 8/10)

All sources consistently point to a significant positive market and consumer reaction to Hims & Hers’ Super Bowl ad, with mentions of increased traffic, app rankings, and a notable rise in stock price.